Evidence map›Paper›PMID 31179204›Full record

ArticleCurrent clinical microbiology reports2019

Toxoplasma: Immunity and Pathogenesis.

Imtiaz A Khan, Charlotte Ouellette, Keer Chen, Magali Moretto

Abstract read
In one paragraph

Article in Current clinical microbiology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. LatentBiomolecules · 2025
    Article
  4. HumanMicroorganisms · 2025
    Article
  5. Article
  6. Surface antigen SAG1 mediatesInfection and immunity · 2025
    Article
  7. Article
  8. Article
  9. Immunomodulatory effect of propolisOpen veterinary journal · 2024
    Article
  10. Article
  11. Review
  12. Ocular manifestations following COVID-19 vaccination.Journal of ophthalmic inflammation and infection · 2023
    Article
  13. Article
  14. Seropositivity of Anti-Tropical medicine and infectious disease · 2023
    Article
  15. Article
  16. scDual-Seq ofFrontiers in immunology · 2023
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Imtiaz A KhanDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington DC 20037.
Charlotte OuelletteDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington DC 20037.
Keer ChenDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington DC 20037.
Magali MorettoDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington DC 20037.
George Washington University · US

Funding

LONG TERM IMMUNITY AGAINST TOXOPLASMOSISR01AI033325 · NIAID · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI KHAN, IMTIAZ AHMED · 1998 to 2020
$6.2M
NIAID NIH HHS R01 AI033325
6 · The paper itself

Abstract

Toxoplasma gondii infection induces a strong immunity in the host. Although the response is manifested by innate response during early infection, adaptive immunity is critical for long-term protection. Amongst the adaptive immune response CD4 T cells play an important helper role for CD8 T cells which are the primary effector cells responsible for controlling the infection. Notwithstanding the induction of robust CD8 T immunity during acute infection, the parasite is not eradicated. One of the reasons for this is the functional exhaustion of CD8 T cells during latent infection. Recent studies from our laboratory have reported that primary cause of CD8 T cell exhaustion is compromised CD4 T cell help during latent toxoplasmosis. CD8 T cell dysfunctionality is preceded by CD4 exhaustion and effector immunity is severely compromised.

Indexed as

CD4 T cellsCD8 T cellsExhaustionIL-12IL-21Toxoplasma

Identifiers

PMID31179204
PMCPMC6547811
OpenAlexW2912049927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.